Tiansheng Pharmaceutical Group Co. Ltd. (002872) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tiansheng Pharmaceutical Group Co. Ltd.

Why is Tiansheng Pharmaceutical Group Co. Ltd. ?

Poor Management Efficiency with a low ROCE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

Poor long term growth as Net Sales has grown by an annual rate of -16.93% and Operating profit at 9.22% over the last 5 years

Flat results in Sep 25

NET PROFIT(HY) At CNY -33.23 MM has Grown at -103.64%
INTEREST(Q) At CNY 4.03 MM has Grown at 10.2%
INVENTORY TURNOVER RATIO(HY) Lowest at 2.59 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 12.10%, its profits have risen by 4.9%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tiansheng Pharmaceutical Group Co. Ltd. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Tiansheng Pharmaceutical Group Co. Ltd.

14.61%

1.39

26.98%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-16.93%

EBIT Growth (5y)

9.22%

EBIT to Interest (avg)

-8.43

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

0.24

Tax Ratio

9.58%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.79

EV to EBIT

-13.42

EV to EBITDA

-226.55

EV to Capital Employed

0.80

EV to Sales

3.18

PEG Ratio

Dividend Yield

ROCE (Latest)

-5.93%

ROE (Latest)

-4.20%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 68.25 MM

RAW MATERIAL COST(Y)

Fallen by -40.42% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 5.07 %

NET PROFIT(Q)

At CNY -8.3 MM has Grown at 59.64%

-13What is not working for the Company

NET PROFIT(HY)

At CNY -33.23 MM has Grown at -103.64%

INTEREST(Q)

At CNY 4.03 MM has Grown at 10.2%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.59 times

NET SALES(Q)

At CNY 116.62 MM has Fallen at -10.38%

Here's what is working for Tiansheng Pharmaceutical Group Co. Ltd.

Operating Cash Flow

Highest at CNY 68.25 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

At CNY -8.3 MM has Grown at 59.64%

over average net sales of the previous four periods of CNY -20.56 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Debt-Equity Ratio

Lowest at 5.07 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -40.42% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tiansheng Pharmaceutical Group Co. Ltd.

Interest

At CNY 4.03 MM has Grown at 10.2%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

At CNY 116.62 MM has Fallen at -10.38%

over average net sales of the previous four periods of CNY 130.12 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Inventory Turnover Ratio

Lowest at 2.59 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio